Chimerix Inc., of Durham, N.C., priced an underwritten public offering of 3.65 million shares of its common stock at a price of $29 per share, for gross proceeds of $105.9 million. The offering is expected to close on or about Nov. 5. Chimerix anticipates using the net proceeds to fund its research and development efforts and for general corporate purposes, including working capital.